Register for email alerts and news feeds:
This journal | BMJ Group
rss
British Journal of Sports Medicine 2006;40:661-663; doi:10.1136/bjsm.2006.027342
Copyright © 2006 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine.

LEADER

Non-steroidal anti-inflammatory drugs in athletes

G Lippi, M Franchini, G C Guidi

Department of Morphological-Biomedical Science, Institute of Chemical and Clinical Microscopy, University of Verona, Verona, Italy

Correspondence to:
Correspondence to:
Professor Lippi
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Ospedale Policlinico G B Rossi, Piazzale Scuro, 10, 37134 Verona, Italy; ulippi@tin.it

Keywords: aspirin; bleeding; injury; non-steroidal anti-inflammatory drugs

The first 150 words of the full text of this article appear below.

Aspirin and the non-steroidal anti-inflammatory drugs (NSAIDs) have been commercially available for decades, and their ability to reduce pain and inflammation is well established. It was first shown nearly 30 years ago that aspirin strongly inhibits platelet function by acetylation of platelet cyclo-oxygenase (COX) at the functionally important amino acid serine 529. This prevents access of the substrate (arachidonic aid) to the catalytic site of the enzyme at tyrosine 385 and results in irreversible inhibition of platelet dependent formation of thromboxane, a powerful promoter of aggregation, for the lifetime of the platelet (7–10 days). Aspirin is about 150–200-fold more potent as an inhibitor of the constitutive isoform of the platelet enzyme (COX-1) than the inducible isoform (COX-2), which is expressed by cytokines, inflammatory stimuli, and some growth factors.1 This explains the different dose requirements of aspirin as an antithrombotic (COX-1) and an anti-inflammatory drug (COX-2).2 Non-aspirin NSAIDs inhibit the activity . . . [Full text of this article]

W F Kean

Correspondence to:
Correspondence to:
W F Kean


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Petroczi, A, Naughton, D P (2009). Popular drugs in sport: descriptive analysis of the enquiries made via the Drug Information Database (DID). Br. J. Sports. Med. 43: 811-817 [Abstract] [Full Text]  
  • Knobloch, K., Bedair, H., Uehara, K., Fu, F. H., Huard, J. (2008). Letter to the Editor * Authors' Response. Am J Sports Med 36: e5-e7 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

 

The journal is co-owned by and the official journal of BASEM

Official journal of ECOSEP

Available online to all members of ACSP, AMSSM and SMNZ